Kashif Shaikh, Susan S Ellenberg, Rine Nakanishi, Peter J Snyder, Juhwan Lee, Nanette K Wenger, Cora E Lewis, Ronald S Swerdloff, Peter Preston, Sajad Hamal, Alisa Stephens-Sheilds, Shalender Bhasin, Lavanya Cherukuri, Jane A Cauley, Jill P Crandall, Glenn R Cunningham, Kristine E Ensrud, Alvin M Matsumoto, Mark E Molich, Venkata M Alla, Divya Birudaraju, Negin Nezarat, Kelash Rai, Shone Almeida, Sion K Roy, Mohammad Sheikh, George Trad, Mathew J Budoff
OBJECTIVE: Recent results from the Cardiovascular Trial of the Testosterone Trials showed that testosterone treatment of older men with low testosterone was associated with greater progression of noncalcified plaque (NCP). We evaluated the effect of anthropometric measures and cardiovascular biomarkers on plaque progression in individuals in the Testosterone Trial. METHODS: The Cardiovascular part of the trial included 170 men aged 65 years or older with low testosterone...
July 1, 2020: Journal of Clinical Endocrinology and Metabolism